Menu
1. Statine: en faut-il à tout âge?
2. Efficacy and safety of statin therapy
3. No potential conflicts of interest
4. Population - Patients séniors
5. La santé en Suisse
6. Population - Patients séniors
7. Time-exposure to low LDL-C
8. ESC
9. The anti-statin lobby strikes again: time to set the record straight
10. Statines pour les séniors
11. Methods
12. Results
13. Lancet 2019
14. Effects on major vascular events per mmol/L reduction in LDL cholesterol by age at randomisation
15. Effects on components of major vascular events per mmol/L reduction in LDL cholesterol in all studies, by age
16. Effects on major vascular events per mmol/L reduction in LDL cholesterol, subdivided by age and by previous vascular disease
17. Effects on vascular death per mmol/L reduction in LDL cholesterol, subdivided by age
18. Webfigure 6
19. Statines - Séniors - Sécurité
20. Statines - Séniors - Sécurité
21. Statines pour les séniors
22. Points forts
23. Statines pour les séniors
24. Conclusions/messages
25. Merci pour votre attention
26. Statines pour les séniors
27. Statines - Les évidences
28. Potential conflicts of interest
29. Methods
30. Statin discontinuation and CV morbidity and mortality
31. Statines pour les séniors
32. Effects on vascular events per mmol/L reduction in LDL cholesterol, subdivided by age and particular trial populations
Statine: en faut-il à tout âge? Pr François Mach, 07.05.19
Resources
Here are some useful links and documents:
Title
Title
Title
FINISH
SUBMIT
NEXT
PREV
Submit All